Two years after co‑founder Delphine Groll relocated to New York, Nabla is scaling its AI‑enabled clinical documentation platform amid fierce competition for hospital contracts. The move reflects a broader scramble among health‑tech firms to embed generative AI in electronic records, promising faster note‑taking and reduced physician burnout.

Investors have poured capital into AI‑driven health solutions, and Nabla’s rapid hiring spurt underscores the pressure to deliver a product that can handle massive data volumes while complying with privacy rules. The company’s engineers work around the clock, often battling jet lag as they coordinate teams across Europe and the U.S., a testament to the intensity of the market race.

Clients cite measurable time savings, and Nabla’s growing user base signals early traction that could translate into sizable revenue streams. With hospitals eager for efficiency gains, the platform’s ability to scale quickly will determine whether it secures a lasting foothold in a sector hungry for AI innovation.